Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
Seoul National University · National University College · +13 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,720
total citations
- FWCI
- 96.53
- Percentile
- 100%
- References
- 30
Citations per year
Authors
17Topics & keywords
Topics
Keywords
- Medicine
- Capecitabine
- Oxaliplatin
- Gastrectomy
- Cancer
- Internal medicine
- Clinical endpoint
- Interim analysis
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.